# XYNOMIC PHARMACEUTICALS HOLDINGS, INC.

XYNOMIC PHARMACEUTICALS HOLDINGS, INC. is a company headquartered in Beijing, China.

## Company overview

- **Legal name:** XYNOMIC PHARMACEUTICALS HOLDINGS, INC.
- **Former names in filing history:** Bison Capital Acquisition Corp. (2017-03-28 to 2019-05-14); Bison Capital Acquisition Corp (2017-03-01 to 2017-06-20)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Beijing, China
- **Incorporated in:** D8
- **Fiscal year end:** December 31
- **SEC CIK:** 0001697805

## About

XYNOMIC PHARMACEUTICALS HOLDINGS, INC. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001697805, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2020-06-01, it reported net income of USD -25,103,835; total assets of USD 937,517 for the fiscal period ended 2019-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2019 (period ended 2019-12-31)

- **Net income:** -$25.1M (USD -25,103,835)
- **Total assets:** $937,517 (USD 937,517)
- **Cash and equivalents:** $92,661 (USD 92,661)
- **Operating cash flow:** -$10.7M (USD -10,674,666)

### FY2018 (period ended 2018-12-31)

- **Net income:** $266,626 (USD 266,626)
- **Total assets:** $63.5M (USD 63,460,798)
- **Cash and equivalents:** $122,615 (USD 122,615)
- **Operating cash flow:** -$687,473 (USD -687,473)
- **Later filings:** Net income, Total assets, Cash and equivalents, Operating cash flow: shown as originally filed; later filings report different values for the same periods.

### FY2017 (period ended 2017-12-31)

- **Net income:** -$41,260 (USD -41,260)
- **Total assets:** $62.5M (USD 62,507,948)
- **Cash and equivalents:** $210,088 (USD 210,088)
- **Operating cash flow:** -$376,076 (USD -376,076)
- **Later filings:** Cash and equivalents: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form 8-K — filed 2020-06-29 — period 2020-06-28 — CURRENT REPORT
- Form 10-K — filed 2020-06-01 — period 2019-12-31 — ANNUAL REPORT
- Form 8-K — filed 2020-05-14 — period 2020-05-14 — CURRENT REPORT
- Form 8-K — filed 2020-03-30 — period 2020-03-26 — CURRENT REPORT
- Form 8-K — filed 2020-03-27 — period 2020-03-27 — CURRENT REPORT
- Form 10-Q — filed 2019-11-14 — period 2019-09-30 — QUARTERLY REPORT
- Form 8-K — filed 2019-09-27 — period 2019-09-27 — CURRENT REPORT
- Form 8-K — filed 2019-09-23 — period 2019-09-23 — CURRENT REPORT
- Form 8-K — filed 2019-09-20 — period 2019-09-20 — CURRENT REPORT
- Form 8-K — filed 2019-09-13 — period 2019-09-13 — CURRENT REPORT
- Form 8-K — filed 2019-09-06 — period 2019-08-30 — CURRENT REPORT
- Form 8-K — filed 2019-08-30 — period 2019-08-30 — FORM 8-K

---

Updated: 2026-10-23T20:09:28Z

Canonical page: https://altss.com/profile/xynomic-pharmaceuticals-holdings-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology